| T41 mutants of beta-catenin aren't phosphorylated | R-HSA-5358752 | 9.08 |
| Signaling by Wnt | R-HSA-195721 | 4.79 |
| misspliced GSK3beta mutants stabilize beta-catenin | R-HSA-5339716 | 9.08 |
| S33 mutants of beta-catenin aren't phosphorylated | R-HSA-5358747 | 9.08 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| S37 mutants of beta-catenin aren't phosphorylated | R-HSA-5358749 | 9.08 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.64 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.89 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.89 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 9.18 |
| truncated APC mutants destabilize the destruction complex | R-HSA-4839744 | 9.18 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.36 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 9.18 |
| S45 mutants of beta-catenin aren't phosphorylated | R-HSA-5358751 | 9.08 |
| AXIN mutants destabilize the destruction complex, activating WNT signaling | R-HSA-4839735 | 9.18 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | R-HSA-4839743 | 9.08 |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.03 |
| truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 9.18 |
| AMER1 mutants destabilize the destruction complex | R-HSA-4839748 | 9.18 |
| Disease | R-HSA-1643685 | 3.33 |